What is Global Cord Blood Financial Strength?
Global Cord Blood has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
Global Cord Blood has no long-term debt (1).
Global Cord Blood's debt to revenue ratio for the quarter that ended in Mar. 2022 was 0.00.
As of today, Global Cord Blood's Altman Z-Score is 0.00.
(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Competitive Comparison of Global Cord Blood's Financial Strength
For the Diagnostics & Research subindustry, Global Cord Blood's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Cord Blood's Financial Strength Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Financial Strength distribution charts can be found below:
* The bar in red indicates where Global Cord Blood's Financial Strength falls into.
Global Cord Blood Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Global Cord Blood's Interest Expense for the
months ended in Mar. 2022 was $0.0 Mil. Its Operating Income for the
months ended in Mar. 2022 was $22.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $0.0 Mil.
Global Cord Blood's Interest Coverage for the quarter that ended in Mar. 2022 is
| Global Cord Blood had no long-term debt (1). |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Global Cord Blood's Debt to Revenue Ratio for the quarter that ended in Mar. 2022 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Global Cord Blood has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Cord Blood (Global Cord Blood) Business Description
Traded in Other Exchanges
N/A
Address
1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Executives
| Kent C Mccarthy |
10 percent owner, other: Mbr 13(d) grp own 10% plus |
930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
| Jayhawk Private Equity Fund Ii Lp |
10 percent owner |
5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
| 7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010 |
other: 13 (d) group owning > 10% |
7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
| 7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010 |
10 percent owner, other: Member of 13(d) group owning m |
7335 COTTONWOOD, SHAWNEE KS 66216 |
| Mccarthy Family Sd, Llc |
10 percent owner, other: 13 (d) group owning > 10% |
7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
| Jhab Fund Ii, Llc |
other: 13(d) group owning > 10% |
7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
| Jhab Management Ii, Llc |
other: 13(d) group owning > 10% |
7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
| Jcf Co Lf, L.p. |
other: 13(d) group owning > 10% |
930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
| Jayhawk Capital Management Llc |
other: Member of the group |
13021 W 74TH ST, SHAWNEE KS 66216 |
| Jayhawk China Fund Cayman Ltd |
other: Member of the group |
930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
| Jayhawk Private Equity Gp Ii, L.p. |
10 percent owner |
5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
| Jayhawk Private Equity, Llc |
10 percent owner |
5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
Global Cord Blood (Global Cord Blood) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CORBF has been successfully added to your